Basic info
Industry
biotechnology research
Sectors
Biotechnology
oncology
Therapeutics
Immunotherapy
T cell therapy
biotechnology
immunology
machine learning
Date founded
2021
Funding rounds raised
Total raised
$16M
from 4 investors over 4 rounds
E
Engimmune Therapeutics raised $16M on May 3, 2022
Investors: Novo Holdings, Pureos Bioventures and Kinled Holding Ltd
E
Engimmune Therapeutics raised $546K on February 21, 2022
Investors: BaseLaunch